← Back to Clinical Trials
Recruiting NCT07715786

NCT07715786 Blood Flow Restriction During Nordic Hamstring Exercise in Elite Adolescent Athletes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07715786
Status Recruiting
Phase
Sponsor Toros University
Condition Healthy Volunteers (HV)
Study Type INTERVENTIONAL
Enrollment 24 participants
Start Date 2026-07-01
Primary Completion 2027-07

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 18 Years
Study Type INTERVENTIONAL
Interventions
Nordic Hamstring ExerciseBlood Flow Restriction Nordic Hamstring Exercise

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 24 participants in total. It began in 2026-07-01 with a primary completion date of 2027-07.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This crossover experimental study aims to compare acute hamstring muscle oxygenation responses during Nordic Hamstring Exercise (NHE) and Blood Flow Restriction Nordic Hamstring Exercise (BFR-NHE) in elite adolescent athletes. Participants will complete both exercise conditions in a randomized order separated by a 7-day washout period. Muscle oxygen saturation will be assessed using near-infrared spectroscopy (MOXY), together with total hemoglobin responses, blood lactate concentration, perceived exertion, and exercise performance variables. The findings may improve understanding of the physiological effects of blood flow restriction during eccentric hamstring exercise in adolescent athletes.

Eligibility Criteria

Inclusion Criteria: * Elite adolescent athletes aged 14 to 18 years. * Licensed athletes with at least 3 years of regular sports participation. * Currently participating in a regular weekly training program. * Physically able to complete the Nordic Hamstring Exercise and study testing protocol. * Willing to participate in the study. * Able to provide written informed consent. * For participants younger than 18 years, written informed consent provided by a parent or legal guardian and assent provided by the participant. Exclusion Criteria: * Hamstring injury within the previous 6 months. * Lower extremity surgery within the previous 6 months. * Current lower extremity pain or musculoskeletal injury that may interfere with exercise performance. * Cardiovascular, vascular, neurological, or other medical conditions that may contraindicate blood flow restriction exercise. * Presence of skin lesions or conditions preventing placement of the blood flow restriction cuff or MOXY sensor. * Inability to complete either exercise condition or follow the study protocol.

Contact & Investigator

Central Contact

İdil Ünlü, Assist. Prof. Dr.

✉ idil.unlu@toros.edu.tr

📞 +90 506 515 66 22

Frequently Asked Questions

Who can join the NCT07715786 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 18 Years, studying Healthy Volunteers (HV). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07715786 currently recruiting?

Yes, NCT07715786 is actively recruiting participants. Contact the research team at idil.unlu@toros.edu.tr for enrollment information.

Where is the NCT07715786 trial being conducted?

This trial is being conducted at Adana, Turkey (Türkiye).

Who is sponsoring the NCT07715786 clinical trial?

NCT07715786 is sponsored by Toros University. The trial plans to enroll 24 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology